Maplight Therapeutics Inc (MPLT)

Finanzdaten der Maplight Therapeutics Inc-Aktie (MPLT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate
	1.48%63.55	64.50	83.38	31.50
Research and Development	0.46%53.44	53.68	64.62	27.09
Operating Income/Loss	1.48%-63.55	-64.50	-83.38	-31.50
	0.78%-60.19	-60.67	-79.55	-29.42
Attributable To Parent	0.78%-60.19	-60.67	-79.55	-29.42
Basic Average Shares	0.34%45.43	45.28	-	0.79
Diluted Average Shares	0.34%45.43	45.28	-	0.79
Basic Earnings Per Share	1.49%-1.32	-1.34	-	-37.18
Diluted Earnings Per Share	1.49%-1.32	-1.34	-	-37.18